Provided by Tiger Trade Technology Pte. Ltd.

ORUKA THERAPEUTICS INC

89.70
-1.4500-1.59%
Volume:249.35K
Turnover:21.95M
Market Cap:5.94B
PE:-44.31
High:91.08
Open:91.00
Low:86.00
Close:91.15
52wk High:115.52
52wk Low:14.67
Shares:66.21M
Float Shares:56.65M
Volume Ratio:0.89
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0242
EPS(LYR):-1.8483
ROE:-18.23%
ROA:-12.95%
PB:5.34
PE(LYR):-48.53

Loading ...

Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Apr 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 08, 2026

Correspondence

Form CORRESP - Correspondence
Mar 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2025

Major Issues Report

Form 8-K - Current report
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 22, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Dec 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 22, 2024

Correspondence

Form CORRESP - Correspondence
Nov 21, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]